Optio Biopharma Solutions welcomes Anne Bruns; Thought Leader in rare disease advocacy and patient perspectives – April 2018

Optio welcomes Anne Bruns, former Executive Director of the Atypical HUS Foundation and a US rare disease community advocate and influencer. Anne understands the needs of the rare disease community and has created a large network of advocacy key opinion leaders representing a myriad of rare disease patient perspectives. Anne has been a driver of several projects designed to improve industry and patient collaboration and the quality of patient engagement across the phases of orphan drug clinical development. Anne brings her expertise and insights to Optio rare disease projects and will lead the Optio rare disease patient/caregiver advisory board and contribute to all rare disease projects.

Leave a Reply